Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACTGene is a privately held U.S. life science tools company that manufactures and distributes research-use products for pharmaceutical, biopharmaceutical, academic, and government laboratories. The company appears to focus on molecular biology and laboratory workflow products including agarose and electrophoresis reagents, PCR enzymes and kits, transfection reagents, microbiology products, and benchtop laboratory instruments. Its business is primarily commercial rather than therapeutic drug development, with products sold through distribution partners worldwide. ACTGene positions itself around cost-effective manufacturing, private-label or distributor support, and broad supply of everyday life science research consumables and equipment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACTGene.